schliessen

Filtern

 

Bibliotheken

Effects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients

Purpose: Left ventricular hypertrophy (LVH) is frequently observed in patients with end-stage renal disease and renal allograft recipients, and is an independent and strong predictor of morbidity and mortality. Presence of a patent arteriovenous fistula (AVF) after renal transplantation may contribu... Full description

Journal Title: International Journal of Artificial Organs Oct 2011, Vol.34(10), pp.1024-1030
Main Author: Gorgulu, N
Other Authors: Caliskan, Y , Yelken, B , Akturk, F , Turkmen, A
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0391-3988 ; DOI: 10.5301/ijao.5000005
Link: http://search.proquest.com/docview/1011217697/?pq-origsite=primo
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest1011217697
title: Effects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients
format: Article
creator:
  • Gorgulu, N
  • Caliskan, Y
  • Yelken, B
  • Akturk, F
  • Turkmen, A
subjects:
  • Kidney Transplantation
  • Blood Pressure
  • Tissue Engineering
ispartof: International Journal of Artificial Organs, Oct 2011, Vol.34(10), pp.1024-1030
description: Purpose: Left ventricular hypertrophy (LVH) is frequently observed in patients with end-stage renal disease and renal allograft recipients, and is an independent and strong predictor of morbidity and mortality. Presence of a patent arteriovenous fistula (AVF) after renal transplantation may contribute to the persistent LVH. We investigated the clinical, laboratory, and echocardiographic findings in patients with renal transplants with or without AVF. Methods: A total of 130 renal transplant recipients were included in this study: 60 hemodialysis patients whose fistulas were still functional, 49 hemodialysis patients whose fistulas were spontaneous stopped or closed, and 21 peritoneal dialysis patients who had never had fistulas created. Laboratory parameters were measured and echocardiographic measurements were performed. Results: There were no significant differences regarding smoking status, blood pressures, or NT-proBNP, hs-CRP, iPTH, and TSH levels between the study groups. Left atrial, right atrial diameters, left ventricle end-diastolic diameter, left ventricle end-systolic diameter, interventricular septum thickness (IVST), left ventricle mass index (LVMI), pulmonary artery pressure (PAP), and ejection fraction were similar in the three groups. In correlation analysis, PAP was significantly correlated with serum uric acid and NT-proBNP levels. Also, there were positive and moderate correlations between the serum uric acid and the IVST. Conclusion: Patent AVFs have not affected cardiovascular abnormalities such as LVH and LV mass index in patients with renal transplant. Hyperuricemia may be associated with increased PAP and high LVMI.
language: eng
source:
identifier: ISSN: 0391-3988 ; DOI: 10.5301/ijao.5000005
fulltext: no_fulltext
issn:
  • 03913988
  • 0391-3988
url: Link


@attributes
ID207413071
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid1011217697
sourceidproquest
recordidTN_proquest1011217697
sourcesystemOther
pqid1011217697
display
typearticle
titleEffects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients
creatorGorgulu, N ; Caliskan, Y ; Yelken, B ; Akturk, F ; Turkmen, A
contributorGorgulu, N (correspondence author)
ispartofInternational Journal of Artificial Organs, Oct 2011, Vol.34(10), pp.1024-1030
identifierISSN: 0391-3988 ; DOI: 10.5301/ijao.5000005
subjectKidney Transplantation ; Blood Pressure ; Tissue Engineering
descriptionPurpose: Left ventricular hypertrophy (LVH) is frequently observed in patients with end-stage renal disease and renal allograft recipients, and is an independent and strong predictor of morbidity and mortality. Presence of a patent arteriovenous fistula (AVF) after renal transplantation may contribute to the persistent LVH. We investigated the clinical, laboratory, and echocardiographic findings in patients with renal transplants with or without AVF. Methods: A total of 130 renal transplant recipients were included in this study: 60 hemodialysis patients whose fistulas were still functional, 49 hemodialysis patients whose fistulas were spontaneous stopped or closed, and 21 peritoneal dialysis patients who had never had fistulas created. Laboratory parameters were measured and echocardiographic measurements were performed. Results: There were no significant differences regarding smoking status, blood pressures, or NT-proBNP, hs-CRP, iPTH, and TSH levels between the study groups. Left atrial, right atrial diameters, left ventricle end-diastolic diameter, left ventricle end-systolic diameter, interventricular septum thickness (IVST), left ventricle mass index (LVMI), pulmonary artery pressure (PAP), and ejection fraction were similar in the three groups. In correlation analysis, PAP was significantly correlated with serum uric acid and NT-proBNP levels. Also, there were positive and moderate correlations between the serum uric acid and the IVST. Conclusion: Patent AVFs have not affected cardiovascular abnormalities such as LVH and LV mass index in patients with renal transplant. Hyperuricemia may be associated with increased PAP and high LVMI.
languageeng
source
version5
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://search.proquest.com/docview/1011217697/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
creatorcontrib
0Gorgulu, N
1Caliskan, Y
2Yelken, B
3Akturk, F
4Turkmen, A
titleEffects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients
descriptionPurpose: Left ventricular hypertrophy (LVH) is frequently observed in patients with end-stage renal disease and renal allograft recipients, and is an independent and strong predictor of morbidity and mortality. Presence of a patent arteriovenous fistula (AVF) after renal transplantation may contribute to the persistent LVH. We investigated the clinical, laboratory, and echocardiographic findings in patients with renal transplants with or without AVF. Methods: A total of 130 renal transplant recipients were included in this study: 60 hemodialysis patients whose fistulas were still functional, 49 hemodialysis patients whose fistulas were spontaneous stopped or closed, and 21 peritoneal dialysis patients who had never had fistulas created. Laboratory parameters were measured and echocardiographic measurements were performed. Results: There were no significant differences regarding smoking status, blood pressures, or NT-proBNP, hs-CRP, iPTH, and TSH levels between the study groups. Left atrial, right atrial diameters, left ventricle end-diastolic diameter, left ventricle end-systolic diameter, interventricular septum thickness (IVST), left ventricle mass index (LVMI), pulmonary artery pressure (PAP), and ejection fraction were similar in the three groups. In correlation analysis, PAP was significantly correlated with serum uric acid and NT-proBNP levels. Also, there were positive and moderate correlations between the serum uric acid and the IVST. Conclusion: Patent AVFs have not affected cardiovascular abnormalities such as LVH and LV mass index in patients with renal transplant. Hyperuricemia may be associated with increased PAP and high LVMI.
subject
0Kidney Transplantation
1Blood Pressure
2Tissue Engineering
3W 30920
general
0English
110.5301/ijao.5000005
2Engineering Research Database
3Technology Research Database
4ProQuest Biological Science Collection
5ProQuest Engineering Collection
6ProQuest Environmental Science Collection
7ProQuest Natural Science Collection
8ProQuest Technology Collection
9ProQuest SciTech Collection
10Agricultural & Environmental Science Database
11Biological Science Database
12Materials Science & Engineering Database
13Natural Science Collection
14SciTech Premium Collection
15Technology Collection
sourceidproquest
recordidproquest1011217697
issn
003913988
10391-3988
rsrctypearticle
creationdate2011
addtitleInternational Journal of Artificial Organs
searchscope
01007443
11007944
210000004
310000005
410000013
510000015
610000022
710000038
810000041
910000043
1010000050
1110000053
1210000120
1310000198
1410000209
1510000217
1610000234
1710000238
1810000250
1910000253
2010000260
2110000265
22proquest
scope
01007443
11007944
210000004
310000005
410000013
510000015
610000022
710000038
810000041
910000043
1010000050
1110000053
1210000120
1310000198
1410000209
1510000217
1610000234
1710000238
1810000250
1910000253
2010000260
2110000265
22proquest
lsr43
01007443false
11007944false
210000004false
310000005false
410000013false
510000015false
610000022false
710000038false
810000041false
910000043false
1010000050false
1110000053false
1210000120false
1310000198false
1410000209false
1510000217false
1610000234false
1710000238false
1810000250false
1910000253false
2010000260false
2110000265false
contributorGorgulu, N
startdate20111001
enddate20111001
citationpf 1024 pt 1030 vol 34 issue 10
lsr30VSR-Enriched:[pqid, eissn, date]
sort
titleEffects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients
authorGorgulu, N ; Caliskan, Y ; Yelken, B ; Akturk, F ; Turkmen, A
creationdate20111001
lso0120111001
facets
frbrgroupid8888443177381624800
frbrtype5
languageeng
creationdate2011
topic
0Kidney Transplantation
1Blood Pressure
2Tissue Engineering
collection
0Engineering Research Database
1Technology Research Database
2ProQuest Biological Science Collection
3ProQuest Engineering Collection
4ProQuest Environmental Science Collection
5ProQuest Natural Science Collection
6ProQuest Technology Collection
7ProQuest SciTech Collection
8Agricultural & Environmental Science Database
9Biological Science Database
10Materials Science & Engineering Database
11Natural Science Collection
12SciTech Premium Collection
13Technology Collection
prefilterarticles
rsrctypearticles
creatorcontrib
0Gorgulu, N
1Caliskan, Y
2Yelken, B
3Akturk, F
4Turkmen, A
jtitleInternational Journal of Artificial Organs
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
aulast
0Gorgulu
1Caliskan
2Yelken
3Akturk
4Turkmen
aufirst
0N
1Y
2B
3F
4A
au
0Gorgulu, N
1Caliskan, Y
2Yelken, B
3Akturk, F
4Turkmen, A
addauGorgulu, N
atitleEffects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients
jtitleInternational Journal of Artificial Organs
risdate20111001
volume34
issue10
spage1024
epage1030
pages1024-1030
issn0391-3988
formatjournal
genrearticle
ristypeJOUR
abstractPurpose: Left ventricular hypertrophy (LVH) is frequently observed in patients with end-stage renal disease and renal allograft recipients, and is an independent and strong predictor of morbidity and mortality. Presence of a patent arteriovenous fistula (AVF) after renal transplantation may contribute to the persistent LVH. We investigated the clinical, laboratory, and echocardiographic findings in patients with renal transplants with or without AVF. Methods: A total of 130 renal transplant recipients were included in this study: 60 hemodialysis patients whose fistulas were still functional, 49 hemodialysis patients whose fistulas were spontaneous stopped or closed, and 21 peritoneal dialysis patients who had never had fistulas created. Laboratory parameters were measured and echocardiographic measurements were performed. Results: There were no significant differences regarding smoking status, blood pressures, or NT-proBNP, hs-CRP, iPTH, and TSH levels between the study groups. Left atrial, right atrial diameters, left ventricle end-diastolic diameter, left ventricle end-systolic diameter, interventricular septum thickness (IVST), left ventricle mass index (LVMI), pulmonary artery pressure (PAP), and ejection fraction were similar in the three groups. In correlation analysis, PAP was significantly correlated with serum uric acid and NT-proBNP levels. Also, there were positive and moderate correlations between the serum uric acid and the IVST. Conclusion: Patent AVFs have not affected cardiovascular abnormalities such as LVH and LV mass index in patients with renal transplant. Hyperuricemia may be associated with increased PAP and high LVMI.
doi10.5301/ijao.5000005
urlhttp://search.proquest.com/docview/1011217697/
eissn17246040
date2011-10